BCYC Q3 2025 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+338.5% YoY

Gross Profit

$12M100.0% margin

Operating Income

-$66M-558.6% margin

Net Income

-$59M-503.7% margin

EPS (Diluted)

$-0.85

QoQ Revenue Growth

+301.8%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$72M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$764M

Total Liabilities

$145M

Stockholders' Equity

$618M

Cash & Equivalents

$648M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$3M	+338.5%
Gross Profit	$12M	-$43M	+127.3%
Operating Income	-$66M	-$64M	-2.7%
Net Income	-$59M	-$51M	-16.3%